Ocular Inflammatory Disease in Patients with Rheumatoid Arthritis Taking Etanercept: Is Discontinuation of Etanercept Necessary? [3]

Journal of Rheumatology

Volumn 30, Issue 12, 2003, Pages 2727-

  Tiliakos, Athan N ^a   Tiliakos, Nicholas A ^b  

^a University Hospitals Richmond Medical Center   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; ETANERCEPT; HLA B27 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; STEROID;

ADULT; ARTHRITIS; CASE REPORT; DISEASE COURSE; EYE DISEASE; FEMALE; HUMAN; INFLAMMATORY DISEASE; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCLERITIS; TREATMENT OUTCOME; UVEITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; REFUSAL TO TREAT; SCLERITIS; TREATMENT OUTCOME; UVEITIS, ANTERIOR;

EID: 0348109362     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Dick AD, Duncan L, Hale G, et al. Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis. J Autoimmunity 1998;11:255-64.
2. Wakefield D, Lloyd A. The role of cytokines in the pathogenesis of inflammatory eye disease. Cytokine 1992;4:1-5.
3. Reiff A, Takei S, Sadeghi S, et al. Etanercept therapy in children with treatment-resistant uveitis. Arthritis Rheum 2001;44:1411-5.
4. El-Shabrawi Y, Herman J. Case series of selective anti-tumor necrosis factor alpha therapy using infliximab in patients with nonresponsive chronic HLA-B27 associated anterior uveitis: comment on the articles by Brandt et al. Arthritis Rheum 2002;46:2821-2.
5. Smith JR, Levinson RD, Holland GN, et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 2001;A5:252-7.
6. Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN. Effect of infliximab on sight-threatening panuveitis in Behcet's disease [letter]. Lancet 2001;358:295-6.